Magnetic Resonance/Infrared Dual-Modal Imaging-Guided Synergistic Photothermal/Photodynamic Therapy Nanoplatform Based on Cu1.96S-Gd@FA for Precision Cancer Theranostics
Lixin Cheng,Dongmiao Sang,Fangyu Zhao,Lili Yang,Zhilin Guo,Xinfeng Zhang,Qiaoqiao Yang,Wenju Qiao,Xiaohong Sun,Xiaohong Guan,Haoyu Wang,Jiannan Wang,Hongyan Zou,Xiu'e Li,Fang Fang,Yang Li,Shujun Zhang,Lina Wu,Huiming Lin,Xilin Sun,Kai Wang
DOI: https://doi.org/10.1016/j.jcis.2022.01.099
IF: 9.9
2022-06-01
Journal of Colloid and Interface Science
Abstract:Developing new nanoplatforms for dynamically and quantitatively visualizing drug accumulation and targeting within tumors is crucial for precision cancer theranostic. However, achieving efficient tumor therapy via synergistic photothermal/photodynamic therapy (PTT/PDT) using a single excitation light source, remains a challenge. In this work, we designed Gd-surface functionalized copper sulfide nanoparticles that were modified with folic acid (FA) (Cu<sub>1.96</sub>S-Gd@FA) to overcome the above limitations and promote PTT/PDT therapeutics. Here, Cu<sub>1.96</sub>S-Gd nanoparticles were synthesized via a coprecipitation method. All samples exhibited high longitudinal relaxivity (up to 12.9 mM<sup>-1</sup> s<sup>-1</sup>) and strong photothermal conversion efficiency (50.6%). Furthermore, the Gd ions promoted electron-hole segregation, inducing the Cu<sub>1.96</sub>S-Gd nanoparticles to generate more reactive oxygen species (ROS) than pure Cu<sub>1.96</sub>S nanoparticles. The Cu<sub>1.96</sub>S-Gd@FA enabled the targeting of folate receptor (FR) and promoted cellular uptake, consequently enhancing oncotherapy efficacy. Compared to non-targeted Cu<sub>1.96</sub>S-Gd, a higher signal enhancement for magnetic resonance (MR) imaging in vivo by Cu<sub>1.96</sub>S-Gd@FA was recorded. Given photothermal ability, the nanoparticles also could be visualized in infrared (IR) imaging. Furthermore, the nanoparticles exhibited biodegradation behavior and achieved good drug elimination performance via renal clearance. Our strategy, integrating Cu<sub>1.96</sub>S-Gd@FA nanoparticles, MR/IR dual-modal imaging, and PTT/PDT into one nanoplatform, demonstrated great potential for anti-breast cancer therapy by effectively targeting FR overexpressed breast cancer cells.
chemistry, physical